Compare ANIP & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | EPAC |
|---|---|---|
| Founded | 2001 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 1999 | 1994 |
| Metric | ANIP | EPAC |
|---|---|---|
| Price | $70.86 | $39.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $105.22 | $54.00 |
| AVG Volume (30 Days) | 339.3K | ★ 510.4K |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 0.10% |
| EPS Growth | ★ 419.23 | 1.18 |
| EPS | ★ 3.86 | 1.72 |
| Revenue | $206,547,000.00 | ★ $652,300,000.00 |
| Revenue This Year | $24.30 | $27.50 |
| Revenue Next Year | $10.96 | $8.27 |
| P/E Ratio | ★ $18.37 | $23.17 |
| Revenue Growth | 2.47 | ★ 5.74 |
| 52 Week Low | $67.38 | $32.35 |
| 52 Week High | $87.89 | $43.97 |
| Indicator | ANIP | EPAC |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 56.07 |
| Support Level | N/A | $33.82 |
| Resistance Level | $83.03 | $43.93 |
| Average True Range (ATR) | 2.48 | 1.75 |
| MACD | -0.14 | 0.10 |
| Stochastic Oscillator | 36.89 | 52.13 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Enerpac Tool Group Corp is an industrial tools, services, technology, and solutions provider serving diverse customers and end markets for mission-critical applications. It designs, manufactures, and distributes branded hydraulic and mechanical tools and provides services and tool rental. Its products include branded tools, cylinders, pumps, hydraulic torque wrenches, engineered heavy lifting technology solutions, and other tools. Its single reportable segment is Industrial Tools & Services (IT&S), serving the general industrial, refining and petrochemical, industrial maintenance, repair and operations (MRO), machining and manufacturing, power generation, infrastructure, mining and other markets. The company generates maximum revenue from the United States of America.